Zanthoxylum austrosinense
Zanthoxylum austrosinense · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Zanthoxylum austrosinense is a botanical species that has garnered significant scientific interest due to its unique therapeutic potential. Researchers have specifically focused on the medicinal properties found within the plant's root system. By utilizing various preparations of these roots, studies aim to harness the natural compounds contained within the tissue. One of the most notable biological activities identified in these root extracts is their antiproliferative effect. Understanding these mechanisms provides crucial insights into the plant's ability to inhibit the growth of certain cells.
- Synonyms
- Zanthoxylum Austrosinense Var. Stenophyllum
- Common names
- Not available
- Family
- Rutaceae
- Distribution
- Africa
- Plant Parts
- Root
Classification
Common Names
Zanthoxylum austrosinense is a versatile plant recognized by several distinct regional names. In many local contexts, it is widely known by its common name, 岭南花椒. When referring specifically to its roots, the species is identified as 岭南花椒根. Additionally, this plant carries the unique and evocative moniker 搜山虎. Understanding these various naming conventions is essential for anyone studying the plant's cultural and botanical significance.
Sources: Catalogue of Life (COL)
Synonyms
Zanthoxylum austrosinense is a distinct botanical species that is often identified through various taxonomic classifications. In scientific literature, it is frequently noted that this plant has the recognized synonym Zanthoxylum austrosinense var. stenophyllum. This variation in naming highlights the complex historical efforts to categorize the plant's specific morphological traits. Understanding these synonymous relationships is essential for researchers seeking to maintain accuracy in botanical databases. Ultimately, recognizing these connections ensures that both names refer to the same unique biological entity.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Zanthoxylum austrosinense is a distinctive biological specimen belonging to the kingdom Plantae. Within this vast kingdom, it is specifically classified under the class Equisetopsida. Its taxonomic journey continues through the order Sapindales, which provides a framework for its evolutionary placement. The plant is further categorized under the family Rutaceae, a group known for its unique aromatic qualities. Ultimately, it finds its specific identity within the genus Zanthoxylum.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Sapindales |
| Family | Rutaceae |
| Genus | Zanthoxylum |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Zanthoxylum austrosinense is a plant species primarily found throughout the temperate regions of Asia. Its geographical footprint is most notably concentrated within the diverse landscapes of China. Specifically, the species maintains a presence across the South-Central portions of the country. It is also widely distributed throughout the Southeast regions of China. These established patterns highlight the plant's specific ecological niche within these East Asian territories.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Zanthoxylum austrosinense has demonstrated significant therapeutic potential through the isolation of various alkaloids from its roots. Recent research has identified several new and known carbazole alkaloids that exhibit potent antiproliferative activities against diverse human cancer cell lines. The study revealed that these compounds possess inhibitory concentrations comparable to the well-known chemotherapy drug cisplatin. In addition to fighting cancer cell growth, these alkaloids also show pronounced anti-inflammatory effects by inhibiting nitric oxide production. Consequently, these findings suggest that the plant could serve as a vital resource in the future development of new anti-cancer and anti-inflammatory medications.
Compounds
Conditions
Zanthoxylum austrosinense contains several alkaloids derived from its roots that demonstrate significant medicinal potential. These isolated compounds exhibit notable antiproliferative activities against a variety of human cancer cell lines. The effectiveness of these alkaloids in treating cancer is comparable to the performance of the positive control, cisplatin. Additionally, the plant's alkaloids show pronounced inhibitory effects on nitric oxide (NO) production. This ability to regulate nitric oxide levels suggests that the plant is a meaningful source for developing new anti-inflammatory agents.
Preparations
Zanthoxylum austrosinense is prepared as roots to facilitate the isolation of various bioactive alkaloids. These specific root extracts yielded three new carbazole alkaloids known as zanthoaustrones A-C. Researchers utilized these root-derived compounds to evaluate significant antiproliferative and anti-inflammatory activities. The study highlights that the alkaloids obtained from the plant's roots show notable potential against human cancer cell lines. Consequently, using the roots of Z. austrosinense serves as a meaningful source for developing new medicinal agents.
Parts used
Zanthoxylum austrosinense serves as a valuable source of bioactive compounds, particularly within its root system. Recent scientific investigations have successfully isolated twelve distinct alkaloids from these roots, including three newly discovered carbazole alkaloids named zanthoaustrones A-C. These chemical constituents have demonstrated impressive antiproliferative activities against various human cancer cell lines, performing similarly to the drug cisplatin. Additionally, the alkaloids exhibited significant anti-inflammatory effects by inhibiting nitric oxide production at levels comparable to hydrocortisone. Such findings suggest that the roots of this plant hold immense potential for the future development of novel anti-cancer and anti-inflammatory medications.